Global Optical Genome Mapping Market, By Component (Instruments v/s Consumables), By Application (Genome Assembly, SV Detection, Microbial Strain Typing, Haplotype Phasing, Others), By End User (Biotechnology & Pharmaceutical Companies, Research & Academic Institutions, Clinical Laboratories, Others), By Region, Competition Forecast & Opportunities, 2026
Global optical genome mapping market is projected to accomplish exemplary growth in the forecast period, 2022-2026 with an impressive CAGR.The market growth can be attributed to the increasing advancements in medicine to find effective and efficient treatments for various evolving chronic diseases.
The optical genome mapping method is highly accurate procedure and is quite affordable; these advantages are sufficiently supporting the growth of the global optical genome mapping market in the next five years.Moreover, increasing biotechnological studies and research is supporting the growth of the market.
Enhanced microbiological methods for new drug development and treatment procedure is one of the major driving factors for the growth of the global optical genome mapping market in the subsequent five years.Small structural variations in the bacterial, protists genome for the drug development procedure is major utilization of the optical genome mapping.
Rapidly increasing bio-pharmaceutical advances for the drug manipulation and advancement for the various disease treatment is also aiding the growth of the global optical genome mapping market. Optical genome mapping is a biotechnical procedure of constructing ordered, genome-wide, high-resolution restriction maps from single, stained molecules of DNA, called optical maps.The complete procedure involves a complex process of DNA barcoding, template nicking, gap formation, fluorochrome incorporation, imaging, and photo bleaching along with repeated cycle of fluorochrome incorporation and photo bleaching.
The process is less time consuming and is less costly as compared to similar usability biotechnological processes. The global optical genome mapping market segmentation is based on component, application, end user, competitional landscape, and regional distribution.Based on component, the market is further divided between instruments and consumables.
Optical genome mapping plays major part in drug development procedures thus, consumable component can be expected to hold the largest revenue shares of the market segment and assert its dominance over the segment in the upcoming five years.Diagnostic prenatal testing for the detection and prevention of genetic disorders optical genome mapping is a novel method is able to detect all classes of structural variations (SVs), including copy number variations (CNVs) and thus provide better testing instruments and testing kits.
The market is expected to support significant growth in the upcoming five years.For example, Irys Instrument reveals genome structure by performing low-cost next-generation mapping at single-molecule resolution.
Irys provides the long-range genomic information required for high-quality de novo assembly and high-resolution discovery of structural variations. These next-generation mapping tools along with next-generation sequencing, can be used especially for building reference genomes. Holding the major shares of the global optical genome mapping market are OpGen, Inc., Bionano Genomics, Inc., Nabsys Inc, Nucleome Informatics Pvt Ltd, France Génomique, among others. Market players are actively involved in the research and technological development in the product developments. The advanced technology has made it possible for the industry to provide excellent services through optical genome mapping. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.
• To analyze the historical growth of the market size of global optical genome mapping market from 2016 to 2019. • To estimate and forecast the market size of global optical genome mapping market from 2020 to 2026 and growth rate until 2026. • To classify and forecast global optical genome mapping market based on component, application, end user, competitional landscape, and regional distribution. • To identify dominant region or segment in the global optical genome mapping market. • To identify drivers and challenges for global optical genome mapping market. • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global optical genome mapping market. • To identify and analyze the profile of leading players operating in global optical genome mapping market. • To identify key sustainable strategies adopted by market players in global optical genome mapping market. The analyst performed both primary as well as exhaustive secondary research for this study.Initially, the analyst sourced a list of manufacturers, suppliers, and distributors across the country.
Subsequently, the analyst conducted primary research surveys with the identified companies.While interviewing, the respondents were also enquired about their competitors.
Through this technique, the analyst could include the manufactures which could not be identified due to the limitations of secondary research. The analyst examined the manufactures, distribution channels and presence of all major players across the country. The analyst calculated the market size of global optical genome mapping market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size.
Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.
Key Target Audience:
• Manufacturers, end users, and other stakeholders • Distributors and suppliers of products and other stakeholders • Organizations, forums, and alliances related to optical genome mapping • Market research and consulting firms The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
In this report, global optical genome mapping market has been segmented into following categories, in addition to the industry trends which have also been detailed below: • Global Optical Genome Mapping Market, By Component: o Instruments o Consumables • Global Optical Genome Mapping Market, By Application: o Genome Assembly o SV Detection o Microbial Strain Typing o Haplotype Phasing o Others • Global Optical Genome Mapping Market, By End User: o Biotechnology & Pharmaceutical Companies o Research & Academic Institutions o Clinical Laboratories o Others • Global Optical Genome Mapping Market, By Region: o North America United States Canada Mexico o Europe Germany France United Kingdom Italy Spain o Asia-Pacific China Japan India South Korea Australia o Middle East & Africa South Africa Saudi Arabia UAE Kuwait o South America Brazil Argentina Colombia
Company Profiles: Detailed analysis of the major companies present in global optical genome mapping market.
With the given market data, we offers customizations according to a company’s specific needs. The following customization options are available for the report:
• Detailed analysis and profiling of additional market players (up to five).
Our reports have been used by over 10K customers, including:
Gastric Inhibitory Polypeptide Receptor - Drugs In Development, 2021 Summary Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) pipeline Target constitutes close to 26 molecules. Out of which approximately 23 molecules are developed by companies...
The global prepacked chromatography columns market reached a value of US$ 2.24 Billion in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 3.5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on...
Global PDGFR Inhibitors Market, Drug Sales & Clinical Trials Insight 2026 Report Analysis & Data Highlights: • Research Methodology • Global & Regional Market Analysis • Global PDGFR Inhibitors Market Opportunity Assessment: > USD 4 Billion • Market & Drug Sales Insight 2020 Till 2026 •...
The Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021 report. The report provides a detailed understanding and analysis of how, why and on what terms companies enter discovery stage partnering deals. These deals are discovery stage whereby the licensee obtains a right or an option...
Retinoic Acid Receptor Gamma - Drugs In Development, 2021 Summary Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) - Retinoic acid receptor gamma (RARG) is a nuclear receptor that is encoded by the RARG gene. RARG bind as heterodimers to the...
The global calcium stearate market exhibited moderate growth during 2015-2020. Calcium stearate (C36H70O4.Ca) is a carboxylate of calcium that is produced by the reaction of stearic acid and calcium oxide. Also known as calcium octadecanoic acid, it has a high melting point of around 356°F and is accessible in both...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the pharmaceutical sterility testing market are Pacific Biolabs, STRERIS Corporation, Boston Analytical, Gibraltar Laboratories, Sartorius AG, SolviasAG, SGS AG, Toxikon, Inc., Pace Analytical Services LLC and Charles River Laboratories International Inc. The global pharmaceutical sterility testing market is expected...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the protein expression market are Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., New England Biolabs and Promega Corporation. The global protein expression market is expected to grow from $2.01 billion in 2020 to $2.13 billion in 2021 at a compound annual growth rate (CAGR) of 6%. The growth...
Pharmaceutical Cartridges market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Pharmaceutical Cartridges Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Pharmaceutical Cartridges types, applications. Further,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.